(Q35058030)

6 August 2017

1 reference

title

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications (English)

1 reference

6 August 2017

Andreas Hüser

1

1 reference

PubMed ID

12562216

6 August 2017

Christian Hofmann

series ordinal

2

1 reference

6 August 2017

1 January 2003

1 reference

Molecular Diagnosis and Therapy

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

1

1 reference

6 August 2017

53-63

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500157

6 August 2017

0 references

cites work

cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

The role of CYP2B6 in human xenobiotic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Inhibitory monoclonal antibody to human cytochrome P450 2B6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Involvement of human liver cytochrome P4502B6 in the metabolism of propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Simple method based on fluorescent detection for the determination of 4-hydroxycyclophosphamide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Metabolism of oxazaphosphorines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

Nicotine metabolism by rat hepatic cytochrome P450s

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Cyclophosphamide pharmacokinetics in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Drug metabolism in human liver in vitro: establishment of a human liver bank.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Allelic discrimination using fluorogenic probes and the 5' nuclease assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500157

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500157

1 reference

6 August 2017

1 reference